Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ming Hou
Background: Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by increased platelet destruction and impaired thrombopoiesis. Platelet indices changes depending on the morphology and volume of platelets. Serum lipids have been found to affect platelet formation and activity in certain diseases, thus induce the corresponding variation of platelet indices.
Objectives: To investigate the correlations between platelet indices, serum lipids and bleeding symptoms in ITP.
Methods: The clinical data from 457 ITP patients were retrospectively collected and analyzed, including platelet indices, serum lipids, hemorrhage and therapeutic regimen.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meet the diagnostic criteria for immune thrombocytopenia.
You may not be if
(1) receiving platelet transfusion within 7 days or ITP-related medication within 3 months (2) treated with lipid-lowing agents, including statins, fibrates, niacin, bile sequestrant resins, ezetimibe and so on.